
    
      This is a multi-center, prospective, double-blind, placebo-controlled parallel study
      investigating the use of BOTOX in the treatment of patients with FHP and associated headache
      using a novel fixed site injection paradigm.

      Fifteen subjects will be randomized to receive BOTOXÂ® and fifteen will receive placebo
      injections. Study subjects will receive one cycle of injections, up to a maximal total dosage
      of 250U. The study duration is approximately 4 months and is composed of a Screening Visit
      (Visit 1, Month -1), a Baseline Visit (Visit 2, Day 0), and three Follow-Up Visits 1 month
      apart (Months 1, 2 and 3).
    
  